Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer’s disease (BLAZE)

被引：0
作者：
Stephen Salloway
Lee A. Honigberg
William Cho
Michael Ward
Michel Friesenhahn
Flavia Brunstein
Angelica Quartino
David Clayton
Deborah Mortensen
Tobias Bittner
Carole Ho
Christina Rabe
Stephen P. Schauer
Kristin R. Wildsmith
Reina N. Fuji
Shehnaaz Suliman
Eric M. Reiman
Kewei Chen
Robert Paul
机构：
[1] The Warren Alpert Medical School of Brown University,Department of Neurology and Psychiatry
[2] Genentech Inc.,undefined
[3] F Hoffmann-La Roche Ltd.,undefined
[4] Banner Alzheimer’s Institute,undefined
来源：
Alzheimer's Research & Therapy | / 10卷
关键词：
Alzheimer’s disease; Biomarkers; Positron emission tomography; Monoclonal antibodies; Antibodies; Humanized;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 168 条
[51]  
Massman PJ(undefined)undefined undefined undefined undefined-undefined
[52]  
Berg L(undefined)undefined undefined undefined undefined-undefined
[53]  
Miller JP(undefined)undefined undefined undefined undefined-undefined
[54]  
Baty J(undefined)undefined undefined undefined undefined-undefined
[55]  
Rubin EH(undefined)undefined undefined undefined undefined-undefined
[56]  
Morris JC(undefined)undefined undefined undefined undefined-undefined
[57]  
Figiel G(undefined)undefined undefined undefined undefined-undefined
[58]  
Sano M(undefined)undefined undefined undefined undefined-undefined
[59]  
Raman R(undefined)undefined undefined undefined undefined-undefined
[60]  
Emond J(undefined)undefined undefined undefined undefined-undefined
12345678910